<DOC>
	<DOCNO>NCT01508676</DOCNO>
	<brief_summary>The purpose study see drug Pennsaid ( Diclofenac ) help reduce pain felt people chronic nerve pain . The drug use 2-4 time day 2 week . The U.S. Food Drug Administration ( FDA ) approve Pennsaid treat osteoarthritis ( bone pain ) , FDA approve Pennsaid treat neuropathic ( nerve ) pain . The research study compare Pennsaid placebo .</brief_summary>
	<brief_title>Effects Pennsaid Clinical Neuropathic Pain</brief_title>
	<detailed_description>The research study compare Pennsaid placebo . The placebo look like Pennsaid , n't contain Pennsaid . The investigator use placebos research see result due study drug reason . At time study investigator give patient Pennsaid . At another time , investigator give patient placebo . The investigator use Quantitative Sensory Testing ( QST ) , temperature test use study drug see Pennsaid helpful reduce people 's nerve pain . In test , small metal plate , size matchbox , put area patient pain . The plate connect computer warm cool plate . The patient use computer mouse button tell u plate feel warm . The QST machine approve Food Drug Administration ( FDA ) . It often use nerve doctor see person neuropathy ( pain cause damage nerve ) .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>1 . Subject 18 80 year age . 2 . Subject Pennsaid topical nonsteroid antiinflammatory drug least one month . 3 . Subject agrees make change his/her current pain medication entire study period . This requirement ensure valid comparison primary secondary measure make study . 4 . Subject VAS pain score 4 begin study . 5 . Subject neuropathic pain condition list least three month . This requirement avoid clinical uncertainty unstable pain condition minimize study variation . 6 . Female subject childbearing age must negative urine pregnancy test initial visit . 1 . Subject document severe liver renal disease affect elimination Pennsaid subject adverse effect Pennsaid organ . ( Renal dysfunction define eGFR &lt; 60 . Hepatic dysfunction define LFTs â‰¥ 3X ULN . ) 2 . Subject pending litigation relate neuropathic pain condition . 3 . Subject active skin lesion open wound site Pennsaid application ( e.g. , active shingle skin lesion ) . 4 . Subject pregnant lactating . 5 . Subject scar tissue sensory deficit site QST . 6 . Subject allergic diclofenac crosssensitivity nonsteroid antiinflammatory drug . 7 . Subject positive urine ( illicit ) drug test . 8 . Subjects experience asthma , urticaria allergic type reaction take aspirin NSAIDs . 9 . Subjects undergo coronary artery bypass surgery . 10 . Subject known history cardiovascular disease , ulcer , gastrointestinal bleed impair renal function . 11 . Subjects currently use NSAIDS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>neuropathic pain</keyword>
	<keyword>postherpetic neuralgia</keyword>
	<keyword>complex regional pain syndrome</keyword>
	<keyword>reflex sympathetic dystrophy</keyword>
</DOC>